Patricia Perez-Galan
Overview
Explore the profile of Patricia Perez-Galan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chamorro-Jorganes A, Profitos-Peleja N, Recasens-Zorzo C, Valero J, Reyes-Garau D, Magnano L, et al.
Neoplasia
. 2025 Feb;
61:101131.
PMID: 39914169
A significant proportion of diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) cases harbor a gain-of-function, heterozygous somatic mutation of the methyltransferase gene EZH2. While this factor is...
2.
Bachiller M, Barcelo-Genestar N, Rodriguez-Garcia A, Alserawan L, Dobano-Lopez C, Gimenez-Alejandre M, et al.
Mol Ther
. 2024 Nov;
33(1):317-335.
PMID: 39563035
CD19 CAR-T therapy has achieved remarkable responses in relapsed/refractory non-Hodgkin lymphoma (NHL). However, challenges persist, with refractory responses or relapses after CAR-T administration linked to CD19 loss or downregulation. Given...
3.
Dobano-Lopez C, Valero J, Araujo-Ayala F, Nadeu F, Gava F, Faria C, et al.
Blood Cancer J
. 2024 May;
14(1):75.
PMID: 38697976
Follicular lymphoma (FL), the most common indolent non-Hodgkin lymphoma, constitutes a paradigm of immune tumor microenvironment (TME) contribution to disease onset, progression, and heterogenous clinical outcome. Here we present the...
4.
Faria C, Gava F, Gravelle P, Valero J, Dobano-Lopez C, Van Acker N, et al.
J Immunother Cancer
. 2023 Oct;
11(10).
PMID: 37899130
Background: Follicular lymphoma (FL), the most common indolent non-Hodgkin's Lymphoma, is a heterogeneous disease and a paradigm of the contribution of immune tumor microenvironment to disease onset, progression, and therapy...
5.
Araujo-Ayala F, Dobano-Lopez C, Valero J, Nadeu F, Gava F, Faria C, et al.
Leukemia
. 2023 Apr;
37(6):1311-1323.
PMID: 37031299
Mantle cell lymphoma (MCL), a rare and aggressive B-cell non-Hodgkin lymphoma, mainly develops in the lymph node (LN) and creates a protective and immunosuppressive niche that facilitates tumor survival, proliferation...
6.
Melchor J, Garcia-Lacarte M, Grijalba S, Arnaiz-Leche A, Pascual M, Panizo C, et al.
J Immunother Cancer
. 2023 Feb;
11(2).
PMID: 36854569
Background: Approximately one-third of diffuse large B cell lymphoma (DLBCL) patients exhibit co-expression of MYC and BCL2 (double-expressor lymphoma, DEL) and have a dismal prognosis. Targeted inhibition of the anti-apoptotic...
7.
Dlouhy I, Armengol M, Recasens-Zorzo C, Ribeiro M, Perez-Galan P, Bosch F, et al.
Haematologica
. 2022 Dec;
107(12):2990.
PMID: 36453521
No abstract available.
8.
Corbera-Bellalta M, Alba-Rovira R, Muralidharan S, Espigol-Frigole G, Rios-Garces R, Marco-Hernandez J, et al.
Ann Rheum Dis
. 2022 Jan;
81(4):524-536.
PMID: 35045965
Background: Effective and safe therapies are needed for the treatment of patients with giant cell arteritis (GCA). Emerging as a key cytokine in inflammation, granulocyte-macrophage colony stimulating factor (GM-CSF) may...
9.
Mozas P, Rivero A, Rivas-Delgado A, Nadeu F, Gine E, Delgado J, et al.
Leuk Lymphoma
. 2021 Nov;
63(4):903-910.
PMID: 34844497
The Prognostic Nutritional Index (PNI), a parameter combining serum albumin concentration and absolute lymphocyte count, is considered a measure of the nutritional and inflammatory status and the host's anti-tumor response....
10.
Bea A, Valero J, Irazoki A, Lana C, Lopez-Lluch G, Portero-Otin M, et al.
FEBS J
. 2021 Nov;
289(9):2540-2561.
PMID: 34796659
Cardiovascular diseases are the leading cause of death globally and more than four out of five cases are due to ischemic events. Cardiac fibroblasts (CF) contribute to normal heart development...